LOX and myocardial ischemia: However, in using this approach, we demonstrated that human LOX over-expression does not modify acute myocardial ischemia-reperfusion injury, as no changes were observed in either infarct size, determined by triphenyltetrazolium staining, LDH release, or functional recovery.